MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1)
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1)
Authors
Keywords
MiR-302, Breast cancer, MEKK1, Drug resistance
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 35, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-02-03
DOI
10.1186/s13046-016-0300-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- miR-302a/b/c/d cooperatively inhibit BCRP expression to increase drug sensitivity in breast cancer cells
- (2016) Yan Wang et al. GYNECOLOGIC ONCOLOGY
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- miR-483-5p determines mitochondrial fission and cisplatin sensitivity in tongue squamous cell carcinoma by targeting FIS1
- (2015) Song Fan et al. CANCER LETTERS
- miR-520h is crucial for DAPK2 regulation and breast cancer progression
- (2015) C-M Su et al. ONCOGENE
- miR-130a activates apoptotic signaling through activation of caspase-8 in taxane-resistant prostate cancer cells
- (2015) Yasunori Fujita et al. PROSTATE
- Dysregulation of microRNA biogenesis and gene silencing in cancer
- (2015) Akiko Hata et al. Science Signaling
- Dysregulation of microRNA biogenesis and gene silencing in cancer
- (2015) Akiko Hata et al. Science Signaling
- P-glycoprotein inhibitors of natural origin as potential tumor chemo-sensitizers: A review
- (2015) Hossam M. Abdallah et al. Journal of Advanced Research
- MiR-130a and MiR-374a Function as Novel Regulators of Cisplatin Resistance in Human Ovarian Cancer A2780 Cells
- (2015) Ningwei Li et al. PLoS One
- Structurally diverse MDM2–p53 antagonists act as modulators of MDR-1 function in neuroblastoma
- (2014) L Chen et al. BRITISH JOURNAL OF CANCER
- The emerging role of tumor-suppressive microRNA-218 in targeting glioblastoma stemness
- (2014) Xingchun Gao et al. CANCER LETTERS
- The MEKK1 PHD ubiquitinates TAB1 to activate MAPKs in response to cytokines
- (2014) N. Charlaftis et al. EMBO JOURNAL
- miR200c Attenuates P-gp-Mediated MDR and Metastasis by Targeting JNK2/c-Jun Signaling Pathway in Colorectal Cancer
- (2014) H. Sui et al. MOLECULAR CANCER THERAPEUTICS
- Molecular aspects of cancer cell resistance to chemotherapy
- (2013) Magali Rebucci et al. BIOCHEMICAL PHARMACOLOGY
- miRNA repression of translation in vitro takes place during 43S ribosomal scanning
- (2012) Emiliano P. Ricci et al. NUCLEIC ACIDS RESEARCH
- MicroRNA-302 Increases Reprogramming Efficiency via Repression of NR2F2
- (2012) Shijun Hu et al. STEM CELLS
- Combinatorial microRNAs: Working together to make a difference
- (2011) Irena Ivanovska et al. CELL CYCLE
- The Nodal inhibitor Lefty is negatively modulated by the microRNA miR-302 in human embryonic stem cells
- (2011) Alicia Barroso-delJesus et al. FASEB JOURNAL
- Genome-wide identification of microRNA targets in human ES cells reveals a role for miR-302 in modulating BMP response
- (2011) I. Lipchina et al. GENES & DEVELOPMENT
- Forced Expression of Heat Shock Protein 27 (Hsp27) Reverses P-Glycoprotein (ABCB1)-mediated Drug Efflux andMDR1Gene Expression in Adriamycin-resistant Human Breast Cancer Cells
- (2011) Ragu Kanagasabai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells
- (2011) Deepa Subramanyam et al. NATURE BIOTECHNOLOGY
- MicroRNA miR-302 Inhibits the Tumorigenecity of Human Pluripotent Stem Cells by Coordinate Suppression of the CDK2 and CDK4/6 Cell Cycle Pathways
- (2010) S.-L. Lin et al. CANCER RESEARCH
- MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells
- (2010) Zhimin Li et al. GYNECOLOGIC ONCOLOGY
- Prognostic Significance of Expression of a Single MicroRNA,miR-181a, in Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study
- (2010) Sebastian Schwind et al. JOURNAL OF CLINICAL ONCOLOGY
- Multiple Drug Resistance Mechanisms in Cancer
- (2010) Bruce C. Baguley MOLECULAR BIOTECHNOLOGY
- Regulation of somatic cell reprogramming through inducible mir-302 expression
- (2010) Shi-Lung Lin et al. NUCLEIC ACIDS RESEARCH
- miR-128b is a potent glucocorticoid sensitizer in MLL-AF4 acute lymphocytic leukemia cells and exerts cooperative effects with miR-221
- (2009) A. Kotani et al. BLOOD
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- Down-Regulation of miR-27a Might Reverse Multidrug Resistance of Esophageal Squamous Cell Carcinoma
- (2009) Hongwei Zhang et al. DIGESTIVE DISEASES AND SCIENCES
- miR-93, miR-98, and miR-197 Regulate Expression of Tumor Suppressor Gene FUS1
- (2009) L. Du et al. MOLECULAR CANCER RESEARCH
- Coordinated Regulation of Cell Cycle Transcripts by p53-Inducible microRNAs, miR-192 and miR-215
- (2008) S. A. Georges et al. CANCER RESEARCH
- Acidosis induces multi-drug resistance in rat prostate cancer cells (AT1)in vitroandin vivoby increasing the activity of the p-glycoproteinviaactivation of p38
- (2008) Christoph Sauvant et al. INTERNATIONAL JOURNAL OF CANCER
- Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin
- (2008) O. Kovalchuk et al. MOLECULAR CANCER THERAPEUTICS
- Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state
- (2008) S.-L. Lin et al. RNA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now